v3.26.1
Condensed Financial Information of the Parent Company - Schedule of Statements of Operations and Comprehensive Income (Loss) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Condensed Income Statements, Captions [Line Items]      
Selling, general and administrative expenses $ 332,979 $ 420,922 $ 598,250
Total operating expenses 752,111 726,221 1,037,300
Loss from operations (490,130) (505,535) (713,983)
Other income 208,602 527,636 558,776
Interest income 33,281 29,073 87,122
Foreign currency translation adjustments 273,972 (223,857) (277,710)
Unrealized gain (loss) on available-for-sales investments 6,729 (10,619) 8,779
Comprehensive income (loss) attributable to shareholders of Sinovac 134,874 (53,483) (175,643)
Parent Company      
Condensed Income Statements, Captions [Line Items]      
Selling, general and administrative expenses 42,770 17,535 11,418
Total operating expenses 42,770 17,535 11,418
Loss from operations (42,770) (17,535) (11,418)
Other income 3,754 5,944 3,133
Interest income 25,917 381 622
Equity earnings (losses) of subsidiaries, net of tax (46,581) 102,115 (5,828)
Net Income (Loss) (59,680) 90,905 (13,491)
Foreign currency translation adjustments 187,825 (133,769) (170,931)
Unrealized gain (loss) on available-for-sales investments 6,729 (10,619) 8,779
Comprehensive income (loss) attributable to shareholders of Sinovac $ 134,874 $ (53,483) $ (175,643)